Cryptosporidium parvum DNA replication proteins
Cryptosporidium parvum DNA replication proteins
批准号:
6751711
负责人:
GUAN ZHU
金额:
$21.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2006-05-31
关键词:
CryptosporidiumDNA binding proteinDNA replicationSDS polyacrylamide gel electrophoresisToxoplasma gondiiautoradiographyconfocal scanning microscopyelectron microscopygene expressionimmunoprecipitationnucleic acid metabolismparasitismposttranslational modificationsprotein structure functionproteomicstransfection
中文摘要
描述(由申请人提供):
微小隐孢子虫引起艾滋病患者的机会性感染之一,目前还没有治疗方法。微小隐孢子虫的发育包括几个不同的细胞周期,即孢子生殖、分生孢子生殖、配子生殖和卵囊形成。在孢子分裂和分生孢子分裂过程中,寄生虫在每个细胞周期内进行增殖,形成4-8个子细胞,这与寄主的复制细胞周期不同,这表明可能有一种独特的机制调节顶端复合体的增殖。复制蛋白A(RPA)是一种真核单链DNA结合蛋白,由3个亚基组成,在DNA的复制、修复和重组过程中发挥多种作用。我们以前已经发现了一个短型微小隐孢子虫RPA大亚基(CpRPA1A,54 kDa),它与人类的RPA大亚基(约70 kDa)不同。最近,从不同于CpRPA1A的寄生虫中鉴定出第二个RPA1同源物(CpRPA1B)。由于人类只有一个RPA1蛋白,CP中存在两个不同的CpRPA1A和1B蛋白,再加上CpRPA1A和1B都缺乏N端调控结构域,因此我们推测微小隐孢子虫不仅拥有独特的DNA复制蛋白,而且在DNA代谢的调节方面可能与宿主不同。由于所有生物的生长和发育都依赖于每个细胞周期中DNA复制的忠实复制,因此,寄生虫特有的DNA复制机制可能被用作治疗隐孢子虫病的新型药物靶点。我们的长期目标是阐明与独特的寄生虫细胞和生命周期相关的CP复制蛋白的结构和功能,以用于化疗探索。该项目的具体目的是利用蛋白质组学、代谢标记、分子工程、免疫标记、共聚焦和电子显微镜以及弓形虫感染系统来研究CpRPA1A和CpRPA1B基因的表达、翻译后加工和功能特性。RPA蛋白已成为多种癌症的化疗靶点。人和微小隐孢子虫RPA蛋白及其功能之间的明显差异支持了寄生虫RPA可能成为潜在药物靶点的观点。这些目标的完成不仅将证明或驳斥我们的假设,而且将为针对寄生虫独特的DNA机制机制的药物发现奠定新的基础。
英文摘要
DESCRIPTION (provided by applicant):
Cryptosporidium parvum causes one of the opportunistic infections among AIDS patients for which no treatment is yet available. The development of C. parvum consists of several distinct cell cycles referred to as sporogony, merogony, gametogony and oocyst formation. During sporogony and merogony, parasites undergo multiplication to form 4 to 8 daughter cells in each cell cycle, which differs from the duplicative cell cycle in its hosts, and suggests that a unique mechanism may regulate apicomplexan multiplications. Replication protein A (RPA) is a eukaryotic single-stranded DNA (ssDNA)-binding protein, consisting of 3 subunits and playing multiple roles in the DNA replication, repair, and recombination. We have previously discovered a short-type C. parvum RPA large subunit (CpRPA1A, 54 kDa) that differs from that of humans (approximately 70 kDa). More recently, a second RPA1 homologue (CpRPA1 B) was identified from the parasite that differs from CpRPA1A. Since humans have only one RPA1 protein, the presence of two distinct CpRPA1A & 1B proteins in Cp, together with the fact that both CpRPA1A & 1B lack the N-terminal regulatory domain, lead us to hypothesize that C. parvum not only possesses unique DNA replication proteins, but possibly also differs from its host in the regulation of DNA metabolism. Since the growth and development of all organisms depend on the faithful replication of DNA replication in each cell cycle, the peculiar DNA replication machinery in the parasite may be pursued as a novel drug target against cryptosporidiosis. Our long-term goal is to elucidate the structure and function of Cp replication proteins associated with the unique parasite cell and life cycles for chemotherapeutic exploration. The specific aim for the project is to investigate the expression, posttranslational processing and functional properties of CpRPA1A and CpRPA1B genes using proteomics, metabolic labeling, molecular engineering, immunolabeling, confocal and electron microscopy, and a Toxoplasma gondii transfection system. RPA proteins have been promising chemotherapeutic targets against various cancers. The apparent differences between human and C. parvum RPA proteins and their functions support the notion that the parasite RPA may serve as a potential drug target. The completion of these aims will not only prove or refute our hypothesis, but also establish a new foundation for the drug discovery targeting the parasite unique DNA mechanism machinery.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Developing Therapeutics against Giardia and Other Anaerobic Protozoa by Targeting Parasite Fatty Acyl-CoA Synthetase (ACS)
-
批准号:9099754
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2015
-
负责人:GUAN ZHU
-
依托单位:
Bacterial-type hexokinase (HK) in the opportunistic parasite Cryptosporidium parv
-
批准号:8898712
-
项目类别:
-
资助金额:$17.78万
-
财政年份:2014
-
负责人:GUAN ZHU
-
依托单位:
Bacterial-type hexokinase (HK) in the opportunistic parasite Cryptosporidium parv
-
批准号:8730780
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2014
-
负责人:GUAN ZHU
-
依托单位:
Evaluation of marketed drugs for rapid development as anti-cryptosporidal agents
-
批准号:8528014
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2012
-
负责人:GUAN ZHU
-
依托单位:
Evaluation of marketed drugs for rapid development as anti-cryptosporidal agents
-
批准号:8285540
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2012
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7846684
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2009
-
负责人:GUAN ZHU
-
依托单位:
Host cell proteins that interact with Cryptosporidium
-
批准号:7540134
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2008
-
负责人:GUAN ZHU
-
依托单位:
Host cell proteins that interact with Cryptosporidium
-
批准号:7690244
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2008
-
负责人:GUAN ZHU
-
依托单位:
Cryptosporidium parvum DNA replication proteins
-
批准号:6654648
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2003
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6336055
-
项目类别:
-
资助金额:$19.65万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7120469
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6532770
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6149246
-
项目类别:
-
资助金额:$4.74万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6642058
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7191624
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6751507
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
FATTY ACID BIOSYTHESIS IN CRYPTOSPORIDIUM PARVUM
-
批准号:6374054
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7392226
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7577360
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
Fatty Acid Biosynthesis in Cryptosporidium parvum
-
批准号:7769923
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2000
-
负责人:GUAN ZHU
-
依托单位:
海外基金